While its critical role as a tumor suppressor function is established in both murine models and human patient data, the mechanisms by which IKAROS regulates enhancer architecture and transcriptional programs in human B-ALL remain less well understood. The gene discussed is IKZF1; the disease is precursor B-cell acute lymphoblastic leukemia.